Clinical decision points for two plasma p‐tau217 laboratory developed tests in neuropathology confirmed samples

Documenti analoghi

• Diagnostic and analytical performance of plasma pTau181 and 217 in a clinical laboratory
  di: Anna Mammel, et al.
  Pubblicazione: (2024)
• Comparison of three plasma p‐tau217 assays to detect PET‐confirmed Alzheimer's pathologies
  di: Sayo Matsuura, et al.
  Pubblicazione: (2026)
• Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
  di: Binita Rajbanshi, et al.
  Pubblicazione: (2025)
• Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
  di: Seyed Hani Hojjati, et al.
  Pubblicazione: (2025)
• Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
  di: Qi Huang, et al.
  Pubblicazione: (2025)